UBS Group’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.35M | Sell |
|
|||||
|
2025
Q2 | $18.1M | Buy |
|
|||||
|
2025
Q1 | $8M | Buy |
|
|||||
|
2024
Q4 | $1.42M | Sell |
|
|||||
|
2024
Q3 | $2.31M | Sell |
|
|||||
|
2024
Q2 | $2.47M | Sell |
|
|||||
|
2024
Q1 | $2.48M | Buy |
|
|||||
|
2023
Q4 | $788K | Sell |
|
|||||
|
2023
Q3 | $1.35M | Buy |
|
|||||
|
2023
Q2 | $806K | Sell |
|
|||||
|
2023
Q1 | $756K | Sell |
|
|||||
|
2022
Q4 | $1.58M | Buy |
|
|||||
|
2022
Q3 | $545K | Sell |
|
|||||
|
2022
Q2 | $752K | Sell |
|
|||||
|
2022
Q1 | $2.08M | Buy |
|
|||||
|
2021
Q4 | $2.88M | Buy |
|
|||||
|
2021
Q3 | $17K | Sell |
|
|||||
|
2021
Q2 | $518K | Sell |
|
|||||
|
2021
Q1 | $1.01M | Buy |
|